Latest project updates
Oncode Institute aims to outsmart cancer and impact lives. To achieve this, Oncode focuses on three pillars: excellent research, intensive collaboration and powerful valorization. The research strategy is focused on understanding the basic mechanisms of cancer to realize the ultimate goal: safer and more effective medical solutions as well as personalized precision diagnostics. Oncode brings together excellent cancer researchers in The Netherlands: 61 research groups from 12 different Dutch research institutes collaborate on 6 interdisciplinary research themes. To speed up the translation of scientific discoveries into clinical applications, Oncode has a dedicated team of specialists to support scientists in the valorization process.
12 partner institutions
61 Principal Investigators
€ 120 million
funding for 5 years
About Oncode Institute
Over the past decades, the scientific and medical community has made tremendous progress in understanding and treating cancer. However, the disease still has a large burden on society as cancer has become the primary cause of death in The Netherlands. In an effort to address this unmet clinical need, Dutch cancer researchers have joined forces within Oncode Institute. To come up with new avenues for treatment and diagnosis, Oncode focuses on better understanding the fundamental mechanisms of cancer biology. With the ultimate goal to improve long-term survival and the quality of life of patients.Oncode serves as a platform for excellent cancer researchers in The Netherlands to collaborate, share knowledge, expertise and technology. As a virtual Institute it stimulates scientific freedom and offers dedicated support to optimize the translation of fundamental insights into clinical applications. Outsmarting cancer, impacting lives. Visit the Oncode website for more information about the project.
Over 800+ Oncode researchers working under a single strategy that focuses on six different research themes:
- Development of novel technologies
- Understanding the critical drivers of tumour growth and the causes of resistance
- Analysis of network perturbations in tumours and tumour-host interactions
- Causes and consequences of genetic instability
- Identification of critical drug combinations and biomarkers for personalized cancer treatments
- Mobilising immune defence
Oncode invests heavily in the transfer of results from fundamental research into clinical applications. A team of dedicated specialists will help Oncode researchers with valorization of their findings. Furthermore, Oncode offers tailored training programs for affiliated researchers and actively invests in diversity through its Young Female Investigator program.
Accelerating innovation by partnership management
Based on its broad experience with partnership management and communication, Lygature has become a partner of Oncode. Lygature supports Oncode Institute with the following services:
- Program management
- Communication & external affairs
- Finance & IT-infrastructure
- Patient engagement
Lygature together with
Project updates
-
Female Junior Investigator Programme - open call for applications
Oncode Institute has opened a call for applications for our Female Junior Investigator Programme (FJIP). Up to eight young female scientists will each be awarded € 150k,- per year during the first phase of Oncode, ending in 2022. The programme aims to support talented female junior investigators who have established their own line of research. Female scientists from all Dutch universities and research institutes can apply for funding. Read more
-
Geert Kops appointed as Scientific Director
The Supervisory Board of Oncode Institute has appointed Geert Kops from the Hubrecht Institute as the new Scientific Director of Oncode. In June 2018, he will take over this important role from Hans Bos. Geert Kops will chair the new Research Management Committee which further consists of Jan Paul Medema (AMC), Jan Schellens (UU), Karin de Visser (NKI) and Madelon Maurice (UMCU). Read more
-
Launch of Oncode Institute: outsmarting cancer and impacting lives
Yesterday, H.M. Queen Máxima officially launched Oncode Institute! 43 excellent cancer research groups in the Netherlands will work together in Oncode Institute to bring fundamental insights into a clinical setting to improve patient outcomes. As Lygature, we are proud to work as a partner in Oncode Institute to support excellent research.
Read more